U. Ankita, A. RaoGururaj, Rao Rao S.G.A, D. Debjani, A. RaoJyothsna
{"title":"The Implication of a Novel Herbal Formulation in Reversal of Drug-Resistance for Cancer Treatment","authors":"U. Ankita, A. RaoGururaj, Rao Rao S.G.A, D. Debjani, A. RaoJyothsna","doi":"10.5530/ctbp.2020.4.44","DOIUrl":null,"url":null,"abstract":"Traditional medicines or herbal medicinal compounds are being increasingly considered as useful complementary and alternative treatments for cancer. A large number of in vitro and in vivo studies have reported the beneficial effects of herbal medicines alone and in combination with conventional therapeutics. We developed a polyherbal formulation Swastharakshak® (SR033), exhibiting anti-tumorigenic property. Although, majorly 5-Fluorouracil (5FU) resulted in necrosis of HeLa cells, however in combination with SR033, the majority of cells underwent apoptosis with an increase of 30%, SR033 alone was considered as an experimental control. Moreover, 5FU and PTX resistance were reversed by SR033 with 2.5×103and 0.17×103 fold, respectively, in resistant HeLa-R cells. We observed a 2 fold decrease in free radicals when treated with SR033 as compared to untreated controls; however, 1.2 fold decrease was observed in SR033 + 5FU groups in comparison to 5FU alone.These results demonstrated that SR033 acts synergistically with 5FU, along with chemo-protective and 5FU resistance reversal property. Hence, SR033 is a potential herbal formulation that could be used effectively with 5FU as a combination therapy for cancer.","PeriodicalId":10980,"journal":{"name":"Current Trends in Biotechnology and Pharmacy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Trends in Biotechnology and Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/ctbp.2020.4.44","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Traditional medicines or herbal medicinal compounds are being increasingly considered as useful complementary and alternative treatments for cancer. A large number of in vitro and in vivo studies have reported the beneficial effects of herbal medicines alone and in combination with conventional therapeutics. We developed a polyherbal formulation Swastharakshak® (SR033), exhibiting anti-tumorigenic property. Although, majorly 5-Fluorouracil (5FU) resulted in necrosis of HeLa cells, however in combination with SR033, the majority of cells underwent apoptosis with an increase of 30%, SR033 alone was considered as an experimental control. Moreover, 5FU and PTX resistance were reversed by SR033 with 2.5×103and 0.17×103 fold, respectively, in resistant HeLa-R cells. We observed a 2 fold decrease in free radicals when treated with SR033 as compared to untreated controls; however, 1.2 fold decrease was observed in SR033 + 5FU groups in comparison to 5FU alone.These results demonstrated that SR033 acts synergistically with 5FU, along with chemo-protective and 5FU resistance reversal property. Hence, SR033 is a potential herbal formulation that could be used effectively with 5FU as a combination therapy for cancer.
期刊介绍:
The Association of Biotechnology and Pharmacy (ABAP) will be useful to form a forum for scientists so that they can bring together to discuss and find scientific solutions to the problems of society. The annual meetings will help the members to share their knowledge and publish their research knowledge particularly by members and fellows of the Association and special care will be taken to provide an opportunity for young scientists. Besides this the association is planned to organize symposia, seminars and workshops on current developments of Biotechnology and Pharmacy particularly on the subject of current scientific interest, and the proceedings of which will be published regularly. And in view of the vast development of science and to disseminate the problems in publication of research work, an international journal of Current Trends in Biotechnology and Pharmacy has been started by ABAP.